Precision Oncology in Liver Cancer : Genomics, Infection, and the Exposome in African and Global Contexts

個数:1
紙書籍版価格
¥42,062
  • 電子書籍

Precision Oncology in Liver Cancer : Genomics, Infection, and the Exposome in African and Global Contexts

  • 著者名:Dlamini PhD, Zodwa (EDT)
  • 価格 ¥34,944 (本体¥31,768)
  • Academic Press(2026/11/06発売)
  • ポイント 317pt (実際に付与されるポイントはご注文内容確認画面でご確認下さい)
  • 言語:ENG
  • ISBN:9780443459252
  • eISBN:9780443459269

ファイル: /

Description

Precision Oncology in Liver Cancer: Genomics, Infection, and the Exposome in African and Global Contexts explores liver cancer through the lens of precision medicine, integrating molecular profiling, environmental exposures, and targeted therapies. The book presents a multidisciplinary approach, covering infectious drivers like HBV/HCV, environmental carcinogens such as aflatoxins, and emerging tools including genomics, AI, and liquid biopsies. It emphasizes African-specific challenges and innovations, with case studies and comparative global insights. This volume equips researchers, clinicians, and policymakers with evidence-based strategies to address liver cancer disparities, offering a forward-looking framework for equitable cancer care and research in Africa and globally.- Integrates infection, genomics, and exposome science to provide a holistic understanding of liver cancer etiology and progression- Presents African case studies alongside global comparisons to contextualize challenges and showcase regionally relevant solutions- Includes future-focused chapters on AI, multi-omics, and ethical frameworks to guide innovation and equitable implementation

Table of Contents

Part I: The liver cancer landscape―Global burdens and African realities (Setting the scene: Epidemiology, disparities, and health systems readiness)1. The global burden of liver cancer―Patterns, inequities, and precision opportunities2. Liver cancer in Africa―Infection, environmental burdens, and data gaps3. Health systems and precision readiness―Policy, equity, and financing gaps in AfricaPart II: Infectious drivers of liver cancer―Viruses, coinfections, and immune disruption (Dissecting virology, immune response, and comorbid infectious contributions)4. Hepatitis B and C-virological mechanisms, genomic alterations, and prevention gaps5. HIV, liver disease, and cancer: The impact of co-infection and immunosuppression6. Parasitic and bacterial infections―The neglected infectious oncogenesis frontierPart III: The exposome and environmental oncology (Cumulative exposure, environmental risks, and culturally linked carcinogens)7. Aflatoxins in African diets―Exposure, TP53 mutations, and food safety policy8. Urbanization, pollution, and industrial waste―The environmental drivers of liver cancer9. Alcohol, herbal remedies, and cultural practices―Unpacking the double-edged swordPart IV: Precision oncology tools―Genomics, microbiome, and digital disruption (Multiomics, technology, and patient empowerment in liver cancer)10. The genomic landscape of liver cancer―Somatic mutations, pathways, and subtypes11. African genomes and the precision gap―Inclusion, diversity, and innovation12. The liver―gut microbiome axis- dysbiosis, inflammation, and oncogenesis13. Liquid biopsy and predictive biomarkers―noninvasive tools for early detection14. Artificial intelligence in liver cancer―From radiomics to smart surveillance15. Patient centric technologies: Empowering individuals in liver cancer carePART V: Ethics, Decolonization, and Future Directions (Towards sustainable, equitable, and African-led liver cancer solutions)16. Integrating multi-omics and systems thinking―the future of liver cancer research17. Decolonizing liver cancer research―Ethics, capacity and local ownership18. Vision for the future: Innovation, collaboration, and a liver cancer-free Africa

最近チェックした商品